Home » Forschung »

 
 

Pharmazeutische Studien

 

Sangart
MP4OX Phase IIb
A multi-center, randomized, double-blind, controlled study to evaluate the safety and efficacy of MP4OX treatment, plus standard treatment, in severely injured trauma patients with acidosis due to hemorrhagic shock.
Studie 2011-2012:  Einschluss 4 Patienten

Sangart
MP4OX Phase IIa
A multi-center, randomized, double-blind, controlled dose-finding study to evaluate the safety and efficacy of MP4OX treatment, plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock.
2010; Einschluss 1 Patient

NovoNordisk
F7Trauma_1711 Phase III
A multi-centre, randomised, double-blind, parallel group, placebo controlled trial to evaluate the efficacy and safety of activated recombinant factor VII (rFVIIa/NovoSeven®/NiaStase®) in severely injured trauma patients with bleeding refractory to standard treatment.
2007-2009; Einschluss 7 Patienten

 

 

 
 
Konzeption & Ausführung: kenHub